Metfromin Accord

Metformin Hydrochloride, the active ingredient in Metfromin Accord, is a biguanide presented as an oral tablet for oral use. It is used to lower elevated blood glucose levels in adults with type 2 diabetes mellitus.

GNH USA supplies Metfromin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is an oral antidiabetic agent indicated for disorders of glucose metabolism.

- Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial blood glucose levels.

Metformin Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient upset stomach often occurring at treatment initiation. - Diarrhoea: loose stools that may improve with continued use. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening accumulation of lactate. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic failure: rare liver dysfunction requiring immediate medical attention.

Metfromin Accord requires careful monitoring and patient education.

- Renal function assessment: evaluate creatinine clearance before initiation and periodically thereafter. - Hepatic impairment: avoid use in patients with significant liver disease. - Contraindication in severe renal dysfunction: do not use if eGFR is below 30 mL/min/1.73 m². - Alcohol consumption: limit intake as it may increase risk of lactic acidosis. - Vitamin B12 monitoring: long‑term therapy may reduce B12 levels; consider periodic testing. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Metformin Hydrochloride can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Diuretics: may impair renal function, necessitating dose adjustment. - Beta‑blockers: can mask hypoglycaemic symptoms. - Oral contraceptives: may modestly increase metformin levels.